Expiriense of Application of Sublingual Form of Ademetionin in Complex Treatment of Non-alcoholic Steatohepatitis

##plugins.themes.bootstrap3.article.sidebar##

PDF (Українська)
Published: Oct 29, 2019
DOI: https://doi.org/10.30841/2307-5112.4.2019.184995
Keywords:
non-alcoholic steatohepatitis, obesity, alcoholic factor, shear wave elastography, lipid blood spectrum, treatment, sublingual ademetionin,

##plugins.themes.bootstrap3.article.main##

Л. С. Бабінець
I. Horbachevsky Ternopil State Medical University, Ukraine

Abstract

The article presents the results of 40 patients with non-alcoholic steatohepatitis in combination with obesity. According to the CAGE questionnaire, the result of a survey of women about the hidden attraction to alcohol was 1,78±0,31, which indicated a lack of traction in them, and among men it was 2,89±0,42 and was high. It was found that 66,97% of patients in the history of the study noted the use of alcoholic beverages, which was evidenced by the presence of alcohol in the genesis of the disease. It has been proved that the use of the drug ademetionin sublingual in the complex therapy of patients with non-alcoholic steatohepatitis in combination with obesity with the available alcohol factor contributes to a significant improvement of clinical syndromes, normalization of lipidogram rates and structural state of the liver and pancreas (according to the displacement wave elastrations) (p<0,05).

##plugins.themes.bootstrap3.article.details##

How to Cite
Бабінець, Л. С. (2019). Expiriense of Application of Sublingual Form of Ademetionin in Complex Treatment of Non-alcoholic Steatohepatitis. Family Medicine, (4), 78–82. https://doi.org/10.30841/2307-5112.4.2019.184995
Issue
No. 4 (2019)
Section
Gastroenterology
Copyright (c) 2020 Л. С. Бабінець

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biography

Л. С. Бабінець, I. Horbachevsky Ternopil State Medical University

Liliia S. Babynets,

Department of Primary Health Care and General Practice of Family Medicine

References

Буеверов А.О. (2007) «Жирная печень»: причины и последствия. Consilium Medicum, 9(9): 74–78.

Делле Кьяє Р., Маріні І. САМе (SAMe) таблетки для розсмоктування. Фармакокінетичні переваги та роль у лікуванні депресії // Med Psicosom. – 2010. – № 55 (1). – Р. 5–13.

Кучерявый Ю.А., Морозов С.В. Гепатопротекторы: рациональные аспекты применения: учеб. пособие для врачей. – Москва: 2012.

Палій І.Г., Заїка С.В., Ліфанов А.В. (2012) Неалкогольна жирова хвороба печінки у контексті метаболічного синдрому: діагностика та лікування в амбулаторній практиці. Укр. мед. часопис, 4(90): 85–87 (http://www.umj.com.ua/article/38151).

Харченко Н.В. (2008) Метаболический синдром в практике гастроэнтеролога. Здоров’я України, 19(1): 5–6.

Хухліна О.С. (2006) Неалкогольна жирова хвороба печінки: етіологія, епідеміологія, особливості перебігу, діагностика, прогноз. Укр. мед. часопис, 1(51): 89–95 (http://www.umj.com.ua/article/525).

Юрьев К.Л. (2012) Адеметионин – гепатопротектор и антидепрессант. Укр. мед. часопис, 1(87): 61–69 (http://www.umj.com.ua/article/28041).

Caballero F., Fernández A., Matías N. et al. (2010) Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L methionine and glutathione. J. Biol. Chem., 285(24): 18528–18536.

Dowman J.K., Tomlinson J.W., Newsome P.N. (2011) Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther., 33(5): 525–540.

Rambaldi A., Gluud C. (2014) Sadenosyl-Lmethionine for alcoholic liver diseases. Cochrane Database Syst. Rev., 4: CD002235.

Sanyal A.J., Campbell-Sargent C., Mirshahi F. et al. (2014) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 120(5): 1183–1192.

http://www.gnosis-bio.com/same2.php